Viridian Therapeutics, Inc.\DE (VRDN) Operating Margin Growth (5y) (2018 - 2026)

Viridian Therapeutics, Inc.\DE (VRDN) Operating Margin Growth (5y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Viridian Therapeutics, Inc.\DE 229.55 Mn 229.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.11 Mn
Dec 31, 2025 7.48 Mn
Jun 30, 2025 -13.86 Mn
Mar 31, 2025 -12.94 Mn
Sep 30, 2024 -9.62 Mn
Jun 30, 2024 -10.00 Mn
Mar 31, 2024 -7.45 Mn
Dec 31, 2023 -9.71 Mn
Sep 30, 2023 -7.02 Mn
Jun 30, 2023 -8.19 Mn
Mar 31, 2023 -7.39 Mn
Dec 31, 2022 -4.62 Mn
Sep 30, 2022 -213,140.00
Jun 30, 2022 -1.05 Mn
Mar 31, 2022 -1.05 Mn
Dec 31, 2021 -1.24 Mn
Sep 30, 2021 -635,908.00
Jun 30, 2021 -134,178.00
Mar 31, 2021 -88,987.00
Dec 31, 2020 -16.73 Mn